🔎 Trials Near Me

Akèy › Adenokasinom Ezofajyen › New York › Rochester

Etid klinik pou Adenokasinom Ezofajyen nan Rochester, NY

5 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Ap rekriteFaz 2/3
  • University of Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Ap rekriteFaz 3
  • University of Rochester, Rochester
  • Wilmot Cancer Institute at Webster, Webster · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05677490

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Ap rekrite
  • University of Rochester Medical Center, Rochester
Laj 18 a 89 · Tout sèks · Mizajou Sep 11, 2026 · NCT05753748

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

Ap rekrite
  • University of Rochester, Rochester
Laj 18 a 89 · Tout sèks · Mizajou Jul 1, 2026 · NCT05530343

Etid Adenokasinom Ezofajyen nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.